Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05481359 · ClinicalTrials.gov registry record

AF-FLOW Registry to Evaluate Electrographic Flow Mapping in Patients Undergoing Ablation for Atrial Fibrillation

A clinical trial of Atrial Fibrillation and Heart Diseases, sponsored by Ablacon.

Completed
Registry status
25
Enrollment target
5
Study locations

NCT05481359 is a study of Atrial Fibrillation and Heart Diseases that has completed, run by Ablacon. The registered enrollment target is 25 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (99% lower). The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05481359, a study of Atrial Fibrillation and Heart Diseases, has completed, sponsored by Ablacon.

COMPLETED
Registry status
25 participants
Enrollment target
5
Study locations

Study Summary

This post-market global registry will evaluate the ability of Electrographic Flow (EGF™) mapping to identify atrial fibrillation (AF) sources and guide ablation therapy in patients with atrial fibrillation in real-world setting.

Conditions Studied

Atrial Fibrillation Heart Diseases Arrhythmias, Cardiac Atrial Fibrillation, Persistent

Interventions

  • DEVICE Electrographic Flow™ (EGF) mapping and ablation

Study Locations (5)

Georgia

  • Piedmont Healthcare - Athens
  • Piedmont Atlanta Hospital - Atlanta

New York

  • Mount Sinai Hospital - New York

South Holland

  • Erasmus MC - Rotterdam

Other

  • Medicover Hospital - Warsaw

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2022-09-12
Est. Completion 2023-11-17

Sponsor

Ablacon

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05481359

The ClinicalTrials.gov registry entry for NCT05481359 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (99% lower). The listed sponsor is Ablacon, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Electrographic Flow™ (EGF) mapping and ablation is the first listed.

NCT05481359 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Georgia, New York, South Holland.

Frequently Asked Questions

What is clinical trial NCT05481359 about?

NCT05481359 is a clinical study titled "AF-FLOW Registry to Evaluate Electrographic Flow Mapping in Patients Undergoing Ablation for Atrial Fibrillation". This post-market global registry will evaluate the ability of Electrographic Flow (EGF™) mapping to identify atrial fibrillation (AF) sources and guide ablation therapy in patients with atrial fibrillation in real-world setting.

What is the current status of trial NCT05481359?

This trial is currently completed. The enrollment target is 25 participants. The study started on 2022-09-12. Estimated completion is 2023-11-17.

What conditions does trial NCT05481359 study?

This clinical trial studies the following conditions: Atrial Fibrillation, Heart Diseases, Arrhythmias, Cardiac, Atrial Fibrillation, Persistent.

What interventions are being tested in trial NCT05481359?

The interventions under investigation include: Electrographic Flow™ (EGF) mapping and ablation (DEVICE).

Who is sponsoring clinical trial NCT05481359?

This trial is sponsored by Ablacon, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05481359 being conducted?

This trial has 5 study locations across Georgia, New York, South Holland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atrial Fibrillation

All registered trials for this condition

Heart Diseases

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.